May 13 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2021 Mar 31, 2020 Dec 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 7 mln 327 mln
(-100.0 pct) (+184.2 pct)
Operating loss 262 mln loss 305 mln loss 886 mln
Recurring loss 264 mln loss 307 mln loss 890 mln
Net loss 262 mln loss 302 mln loss 892 mln
EPS loss 13.37 yen loss 20.93 yen loss 45.33 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T